Astellas Pharma Inc. (FRA:YPH)
Germany
· Delayed Price · Currency is EUR 10.76
+0.05 (0.51%)
At close: Dec 5, 2025
Astellas Pharma Ratios and Metrics
Market cap in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 19,814 | 15,998 | 18,058 | 23,412 | 26,092 | 24,354 | Upgrade
|
| Market Cap Growth | 4.85% | -11.41% | -22.87% | -10.27% | 7.14% | -7.27% | Upgrade
|
| Enterprise Value | 22,322 | 20,542 | 21,852 | 20,799 | 23,501 | 22,002 | Upgrade
|
| Last Close Price | 10.76 | 8.55 | 9.10 | 11.49 | 12.08 | 10.99 | Upgrade
|
| PE Ratio | 27.55 | 51.03 | 172.88 | 34.26 | 28.37 | 26.22 | Upgrade
|
| PS Ratio | 1.71 | 1.35 | 1.84 | 2.23 | 2.72 | 2.53 | Upgrade
|
| PB Ratio | 2.13 | 1.71 | 1.85 | 2.24 | 2.41 | 2.28 | Upgrade
|
| P/TBV Ratio | 21.73 | - | - | 5.48 | 6.59 | 7.02 | Upgrade
|
| P/FCF Ratio | 9.40 | 16.44 | 21.92 | 11.61 | 15.53 | 11.48 | Upgrade
|
| P/OCF Ratio | 8.61 | 13.31 | 17.09 | 10.32 | 13.67 | 10.30 | Upgrade
|
| EV/Sales Ratio | 2.01 | 1.74 | 2.22 | 1.98 | 2.45 | 2.29 | Upgrade
|
| EV/EBITDA Ratio | 7.21 | 7.19 | 12.63 | 8.90 | 10.64 | 8.83 | Upgrade
|
| EV/EBIT Ratio | 11.03 | 12.62 | 28.62 | 12.97 | 14.53 | 11.38 | Upgrade
|
| EV/FCF Ratio | 10.59 | 21.11 | 26.53 | 10.31 | 13.98 | 10.37 | Upgrade
|
| Debt / Equity Ratio | 0.46 | 0.62 | 0.63 | 0.14 | 0.15 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 1.32 | 2.03 | 3.57 | 0.61 | 0.72 | 0.86 | Upgrade
|
| Debt / FCF Ratio | 2.02 | 5.95 | 7.50 | 0.70 | 0.94 | 1.01 | Upgrade
|
| Asset Turnover | 0.58 | 0.55 | 0.53 | 0.63 | 0.56 | 0.54 | Upgrade
|
| Inventory Turnover | 1.32 | 1.28 | 1.38 | 1.76 | 1.60 | 1.56 | Upgrade
|
| Quick Ratio | 0.76 | 0.79 | 0.69 | 1.13 | 1.05 | 1.15 | Upgrade
|
| Current Ratio | 1.03 | 1.13 | 0.93 | 1.45 | 1.34 | 1.47 | Upgrade
|
| Return on Equity (ROE) | 7.95% | 3.26% | 1.10% | 6.65% | 8.72% | 9.01% | Upgrade
|
| Return on Assets (ROA) | 6.68% | 4.77% | 2.58% | 6.05% | 5.92% | 6.83% | Upgrade
|
| Return on Capital (ROIC) | 9.58% | 6.52% | 3.61% | 8.55% | 8.17% | 9.31% | Upgrade
|
| Return on Capital Employed (ROCE) | 17.40% | 11.60% | 5.50% | 13.40% | 13.30% | 14.90% | Upgrade
|
| Earnings Yield | 3.63% | 1.96% | 0.58% | 2.92% | 3.52% | 3.81% | Upgrade
|
| FCF Yield | 10.64% | 6.08% | 4.56% | 8.62% | 6.44% | 8.71% | Upgrade
|
| Dividend Yield | 4.18% | 5.35% | 4.71% | 3.62% | 3.07% | 2.94% | Upgrade
|
| Payout Ratio | 106.09% | 254.19% | 684.38% | 101.66% | 68.69% | 63.15% | Upgrade
|
| Buyback Yield / Dilution | 0.07% | 0.14% | 1.39% | 1.38% | 0.41% | 1.03% | Upgrade
|
| Total Shareholder Return | 4.25% | 5.49% | 6.11% | 5.00% | 3.48% | 3.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.